Varian Medical Systems Reports Results for Second Quarter of Fiscal...(s; the impact of health care reforms and...),Health

Date:4/29/2009

s; the impact of health care reforms, and/or third-party reimbursement levels and credit availability for capital expenditures for cancer care; demand for the company's products; the company's ability to develop and commercialize new products; the company's ability to complete the planned sale of instruments portion of the company's ACCEL proton therapy business; the company's reliance on sole or limited-source suppliers; the impact of reduced or limited demand by sole purchasers of certain X-ray tubes; the company's ability to maintain or increase operating margins; the impact of competitive products and pricing; the company's ability to meet Food and Drug Administration and other regulatory requirements for product clearances or to comply with Food and Drug Administration and other regulatory regulations or procedures; the ability to make strategic acquisitions and to successfully integrate the acquired operations into the company's business; the company's ability to protect the company's intellectual property; the potential loss of key distributors or key personnel; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

A summary of earnings and other financial information follows.

                     Varian Medical Systems, Inc. and Subsidiaries
                      Condensed Consolidated Statements of Earnings
                                      (Unaudited)

                                      Q2 QTR    Q2 QTR    Q2 YTD    Q2 YTD
                                       2009      2008      2009      2008
     (Dollars and shares in
      millions, except per share
      amounts)
     Net orders                       $524.2     51
'/>"/>
SOURCE  Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 
Related medicine news :

1. Varian, Inc. Reports Second Quarter 2009 Results
2. Worlds largest DNA scan for autism uncovers new gene variant for disorder
3. MCG participating in national study to identify genetic variants in schizophrenia
4. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
5. Image-guided treatment helping women with tubo-ovarian abscesses avoid unnecessary surgery
6. Genetic variants predict recurrence of bladder cancer, patient survival
7. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
8. Chemo Combo Shows Promise Against Ovarian Cancer
9. Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
10. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, and X-Ray Tubes at the CMEF Show in Shenzhen, China
11. Gene Variant Tied to Schizophrenia